Back to top

OraSure receives FDA Emergency Use Authorization for OraQuick Ebola test

OraSure (OSUR) announced that it has received Emergency Use Authorization from the FDA for its second generation OraQuick Ebola 2.0 Rapid Antigen T...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

OraSure Technologies, Inc. (OSUR)